Long-term outcomes of directly observed therapy in a low tuberculosis incidence setting

C. C. Dobler, A. B. H. Crawford, P. J. Jelfs, G. L. Gilbert, G. B. Marks (Sydney, NSW, Australia)

Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Session: Epidemiological and clinical aspects of tuberculosis control
Session type: E-Communication Session
Number: 3036
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. C. Dobler, A. B. H. Crawford, P. J. Jelfs, G. L. Gilbert, G. B. Marks (Sydney, NSW, Australia). Long-term outcomes of directly observed therapy in a low tuberculosis incidence setting. Eur Respir J 2008; 32: Suppl. 52, 3036

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Claudia Dobler - 07.10.2008 14:54
additional data
Thanks, Frank. The article will be in the print version of the ERJ in January 2009, and has been published online in ERJ Express on October 1, 2008 as doi: 10.1183/09031936.00104108 I can send you some additional data on trends in TB incidence stratified by foreig-born people versus Australians within the next couple of weeks. Kind regards, Claudia Dobler

Frank Vanleth - 07.10.2008 09:57
additional data available?
Dear Claudia, Thanks for the nice presentation this morning. Do you have additional data on trends in TB incidence starified by foreigners versus australians? Is there anything published on this? Greetings Frank van Leth KNCV Tuberculosis Foundation The Hague, The Netherlands vanlethf@kncvtbc.nl
You must Login to comment this presentation.


Related content which might interest you:
Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004

Long-term effectiveness of surgery treatment of TB patients
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020


Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis
Source: Eur Respir J , 49 (3) 1601799; DOI: 10.1183/13993003.01799-2016
Year: 2017




Smoking adversely affects treatment response, outcome and relapse in tuberculosis
Source: Eur Respir J 2015; 45: 738-745
Year: 2015



Predicting outcomes and drug resistance with standardised treatment of active tuberculosis
Source: Eur Respir J 2010; 36: 870-877
Year: 2010



The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses
Source: Eur Respir J 2001; 18: Suppl. 33, 473s
Year: 2001

Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program
Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban
Year: 2008

Relationship between active TB case finding and treatment outcomes
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021


Influence of social adaptation of tuberculosis patients on the TB form and a chemotherapy outcomes
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012

Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
Source: Eur Respir J 2015; 45: 1498-1501
Year: 2015


Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with advanced HIV disease
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008

Long-term results of drug resistant tuberculosis treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 378s
Year: 2006

The effectiveness and safety of empirical anti-TB therapy in a population with high TB prevalence
Source: Eur Respir J 2001; 18: Suppl. 33, 468s
Year: 2001

On the efficiency of the long-term hospitalization treatment of patients with social problems with severe pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 369s
Year: 2002

Factors preventing better treatment completion among MDR TB cases in a rich-resource setting
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010


Treatment outcome of MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008


Factors affecting outcomes of individualised treatment for drug resistant tuberculosis in an endemic region>
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017

The clinical effect of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease - including a long-term follow-up study
Source: Eur Respir J 2004; 24: Suppl. 48, 721s
Year: 2004

Does hospitalization influence tuberculosis’ treatment outcome? – A Portuguese nationwide study
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018